SpringerLink
Log in

Effect of nin**’yoeito and ginseng extracts on oxaliplatin-induced neuropathies in mice

  • Original Paper
  • Published:
Journal of Natural Medicines Aims and scope Submit manuscript

Abstract

Oxaliplatin (L-OHP) is a platinum-based anticancer agent used to treat various types of cancer. It frequently causes acute and chronic peripheral neuropathies, such as cold allodynia and mechanical hyperalgesia. Nin**’yoeito (NYT) is a formula used in traditional Japanese Kampo medicine to improve recovery from diseases and other medical disorders. We previously reported that treatment with a boiling-water extract of NYT prevented L-OHP-induced damage to neurite-like outgrowths from differentiated PC12 cells. The objectives of the present study were to evaluate the in vivo effects of NYT on L-OHP-induced neuropathic pain in mice and identify the active ingredients in NYT. Treatment with NYT extract significantly ameliorated both cold allodynia and mechanical hyperalgesia induced by L-OHP. While L-OHP treatment suppressed neurite outgrowths from primary dorsal root ganglion cells in vitro, NYT extract blocked this suppression in a concentration-dependent manner. Among the herbal components of NYT, the extract of ginseng (Panax ginseng roots) showed a protective effect against neurite damage induced by L-OHP, and one of its active ingredients was identified as ginsenoside Rg3. Ginseng extract partially relieved L-OHP-induced neuropathic pain in mice. Our results suggest that NYT could be an attractive agent for treating L-OHP-induced neuropathic pain, and that the active ingredient of NYT may be ginseng.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1a–d
Fig. 2
Fig. 3a–c
Fig. 4a–d

Similar content being viewed by others

References

  1. Grothey A, Goldberg RM (2004) A review of oxaliplatin and its clinical use in colorectal cancer. Expert Opin Pharmacother 5:2159–2170

    Article  CAS  Google Scholar 

  2. Qvortrup C, Yilmaz M, Ogreid D, Berglund A, Balteskard L, Ploen J, Fokstuen T, Starkhammar H, Sorbye H, Tveit K, Pfeiffer P (2008) Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil. Ann Oncol 19:1154–1159

    Article  CAS  Google Scholar 

  3. Gourgou-Bourgade S, Bascoul-Mollevi C, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y, Adenis A, Raoul JL, Boige V, Berille J, Conroy T (2013) Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial. J Clin Oncology 31:23–29

    Article  CAS  Google Scholar 

  4. Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR, Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom (2008) Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358:36–46

    Article  CAS  Google Scholar 

  5. Yamada Y, Takahari D, Matsumoto H, Baba H, Nakamura M, Yoshida K, Yoshida M, Iwamoto S, Shimada K, Komatsu Y, Sasaki Y, Satoh T, Takahashi K, Mishima H, Muro K, Watanabe M, Sakata Y, Morita S, Shimada Y, Sugihara K (2013) Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol 14:1278–1286

    Article  CAS  Google Scholar 

  6. Pasetto LM, D’Andrea MR, Rossi E, Monfardini S (2006) Oxaliplatin-related neurotoxicity: how and why? Crit Rev Oncol Hematol 59:159–168

    Article  Google Scholar 

  7. Carozzi VA, Canta A, Chiorazzi A, Cavaletti G (2014) Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms? Neurosci Lett 596:90–107

    Article  Google Scholar 

  8. Bensky D, Clavey S, Stöger E (2004) Chinese herbal medicine—materia medica, 3rd edn. Eastland, Seattle

  9. Suzuki T, Yamamoto A, Ohsawa M, Motoo Y, Mizukami H, Makino T (2015) Nin**’yoeito and ginseng extract prevent oxaliplatin-induced neurodegeneration in PC12 cells. J Nat Med 69:531–537

    Article  CAS  Google Scholar 

  10. The Society of Japanese Pharmacopoeia (2016) The Japanese pharmacopoeia seventeenth edition (JPXVII). Yakuji-Nippo, Tokyo

    Google Scholar 

  11. Gao S, Kushida H, Makino T (2017) Ginsenosides, ingredients of the root of Panax ginseng, are not substrates but inhibitors of sodium-glucose transporter 1. J Nat Med 71:131–138

    Article  CAS  Google Scholar 

  12. Ohsawa M, Otake S, Murakami T, Yamamoto S, Makino T, Ono H (2014) Gabapentin prevents oxaliplatin-induced mechanical hyperalgesia in mice. J Pharmacol Sci 125:292–299

    Article  CAS  Google Scholar 

  13. Suzuki T, Miyamoto K, Yokoyama N, Sugi M, Kagioka A, Kitao Y, Adachi T, Ohsawa M, Mizukami H, Makino T (2016) Processed aconite root and its active ingredient neoline may alleviate oxaliplatin-induced peripheral neuropathic pain. J Ethnopharmacol 186:44–52

    Article  Google Scholar 

  14. Dixon WJ (1980) Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20:441–462

    Article  CAS  Google Scholar 

  15. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55–63

    Article  CAS  Google Scholar 

  16. Ushio S, Egashira N, Sada H, Kawashiri T, Shirahama M, Masuguchi K, Oishi R (2012) Gosha**kigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents. Eur J Cancer 48:1407–1413

    Article  CAS  Google Scholar 

  17. Kitamura R, Andoh T, Fushimi H, Komatsu K, Shibahara N, Kuraishi Y (2013) Involvement of descending monoaminergic systems in antiallodynic effect of gosha**kigan in oxaliplatin-treated mice. J Tradit Med 30:183–189

    Google Scholar 

  18. Mizuno K, Kono T, Suzuki Y, Miyagi C, Omiya Y, Miyano K, Kase Y, Uezono Y (2014) Gosha**kigan, a traditional Japanese medicine, prevents oxaliplatin-induced acute peripheral neuropathy by suppressing functional alteration of TRP channels in rat. J Pharmacol Sci 125:91–98

    Article  CAS  Google Scholar 

  19. Mizuno K, Shibata K, Komatsu R, Omiya Y, Kase Y, Koizumi S (2016) An effective therapeutic approach for oxaliplatin-induced peripheral neuropathy using a combination therapy with gosha**kigan and bushi. Cancer Biol Ther 17:1206–1212

    Article  CAS  Google Scholar 

  20. Kato Y, Tateai Y, Ohkubo M, Saito Y, Amagai SY, Kimura YS, Iimura N, Okada M, Matsumoto A, Mano Y, Hirosawa I, Ohuchi K, Tajima M, Asahi M, Kotaki H, Yamada H (2014) Gosha-**ki-gan reduced oxaliplatin-induced hypersensitivity to cold sensation and its effect would be related to suppression of the expression of TRPM8 and TRPA1 in rats. Anticancer Drugs 25:39–43

    Article  CAS  Google Scholar 

  21. Oki E, Emi Y, Kojima H, Higashijima J, Kato T, Miyake Y, Kon M, Ogata Y, Takahashi K, Ishida H, Saeki H, Sakaguchi Y, Yamanaka T, Kono T, Tomita N, Baba H, Shirabe K, Kakeji Y, Maehara Y (2015) Preventive effect of gosha**kigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study. Int J Clin Oncol 20:767–775

    Article  CAS  Google Scholar 

  22. Ahn BS, Kim SK, Kim HN, Lee JH, Lee JH, Hwang DS, Bae H, Min BI, Kim SK (2014) Gyejigachulbu-tang relieves oxaliplatin-induced neuropathic cold and mechanical hypersensitivity in rats via the suppression of spinal glial activation. Evid Based Complement Altern Med 2014:436482

    Article  Google Scholar 

  23. Deng B, Jia L, Pan L, Song A, Wang Y, Tan H, **ang Q, Yu L, Ke D (2016) Wen-Luo-Tong prevents glial activation and nociceptive sensitization in a rat model of oxaliplatin-induced neuropathic pain. Evid Based Complement Altern Med 2016:3629489

    Google Scholar 

  24. Andoh T, Mizoguchi S, Kuraishi Y (2017) Shakuyakukanzoto attenuates oxaliplatin-induced cold dysesthesia by inhibiting the expression of transient receptor potential melastatin 8 in mice. J Tradit Complement Med 7:30–33

    Article  Google Scholar 

  25. Gauchan P, Andoh T, Kato A, Sasaki A, Kuraishi Y (2009) Effects of the prostaglandin E1 analog limaprost on mechanical hyperalgesia caused by chemotherapeutic agents in mice. J Pharm Sci 109:469–472

    Article  CAS  Google Scholar 

  26. Pang H, Wang HL, Fu L, Su CY (2001) Pharmacokinetic studies of 20(R)-ginsenoside Rg3 in human volunteers. Acta Pharma Sin 36:170–173

    CAS  Google Scholar 

  27. Kim C, Lee JH, Kim W, Li D, Kim Y, Lee K, Kim SK (2016) The suppressive effects of cinnamomi cortex and its phytocompound coumarin on oxaliplatin-induced neuropathic cold allodynia in rats. Molecules 21:E1253

    Article  Google Scholar 

  28. Di Cesare Mannelli L, Pacini A, Micheli L, Femia AP, Maresca M, Zanardelli M, Vannacci A, Gallo E, Bilia AR, Caderni G, Firenzuoli F, Mugelli A, Ghelardini C (2017) Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy? Sci Rep 7:42021

    Article  Google Scholar 

  29. Wang CZ, Yuan CS (2008) Potential role of ginseng in the treatment of colorectal cancer. Am J Chin Med 36:1019–1028

    Article  CAS  Google Scholar 

  30. Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, Li XK, Tang W (2010) Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trend 4:297–307

    Google Scholar 

Download references

Acknowledgements

This research was supported by Grant-in-Aid for Scientific Research (KAKENHI) C #16K09267 (2016), and the Kidani Memorial Trust (2016).

Author information

Authors and Affiliations

  1. Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, 467-8603, Japan

    Toshiaki Suzuki, Ayano Yamamoto, Hajime Mizukami & Toshiaki Makino

  2. Department of Cellular Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya, 464-8601, Japan

    Toshiaki Suzuki

  3. Department of Neuropharmacology, Graduate School of Pharmaceutical Sciences, Nagoya, 467-8603, Japan

    Masahiro Ohsawa

  4. Department of Medical Oncology, Kanazawa Medical University, Uchinada, Ishikawa, 920-0293, Japan

    Yoshiharu Motoo

  5. The Kochi Prefectural Makino Botanical Garden, Kochi, 781-8125, Japan

    Hajime Mizukami

Authors
  1. Toshiaki Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ayano Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masahiro Ohsawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshiharu Motoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hajime Mizukami
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Toshiaki Makino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toshiaki Makino.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suzuki, T., Yamamoto, A., Ohsawa, M. et al. Effect of nin**’yoeito and ginseng extracts on oxaliplatin-induced neuropathies in mice. J Nat Med 71, 757–764 (2017). https://doi.org/10.1007/s11418-017-1113-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11418-017-1113-6

Keywords

Search

Navigation